Overview

Study to Assess the Long Term Safety and Tolerability of ACT-541468 in Adult and Elderly Subjects Suffering From Difficulties to Sleep

Status:
Completed

Trial end date:
2021-02-22

Target enrollment:

Participant gender:

Summary

Study to assess the long term safety and tolerability of ACT-541468 in adult and elderly subjects suffering from difficulties to sleep

Phase:

Phase 3

Details

Lead Sponsor:

Idorsia Pharmaceuticals Ltd.